tbuckley/cabot-search huggingface dataset:
Dual Inhibition of Histone and DNA Methylation in AML Enhances the Effectiveness of TCR-Based Cellular Therapy through Upregulation of Surface MHC Class I/p53 Antigen Complex
Authors: Ulrike Regina Schmits, Edite Antunes Ferreira, Borhane Guezguez, David Gomez-Zepeda, Stefan Tenzer, Kevin Jan Legscha, Matthias Theobald, Hakim Echchannaoui
Journal: Blood (2024)
The Ability of Currently Used Scoring Systems to Predict 30 and 100-Days Non-Relapse Mortality Among Older Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Amir Tafesh, Dana Yehudai-Ofir, Ofrat Beyar-Katz, Hazim Khatib, Baher Krayem, Avraham Frisch, Tsila Zuckerman, Israel Henig
Journal: Blood (2024)
Delayed Immune Reconstitution and Increased Infections in Allogeneic Transplant Recipients with B Cell Malignancies Treated Previously with CAR T-Cell Therapy
Authors: Jamila Mammadova, Yanina Pasikhova, Jongphil Kim, Junmin Whiting, Farhad Khimani, Michael D. Jain, Sayeef Mirza, Rawan Faramand, Julio C. Chavez, Bijal D Shah, Olga Klinkova, Aliyah Baluch, Jose L. Ochoa-Bayona, Fabiana Perna, Taiga Nishihori, Nelli Bejanyan, Frederick Locke, Aleksandr Lazaryan
Journal: Blood (2024)
Artificial Intelligence-Based Quantitative Bone Marrow Pathology Analysis for Myeloproliferative Neoplasms
Authors: Dandan Yu, Hong-Ju Zhang, Yanyan Song, Yuan Tao, Fengyuan Zhou, Ziyi Wang, Rongfeng Fu, Ting Sun, Huan Dong, Wenjing Gu, Renchi Yang, Zhijian Xiao, Qi Sun, Lei Zhang
Journal: Blood (2024)
Very Low Dose Radiotherapy (VLDRT) with 4 Gy for Potentially-Curable Indolent Non-Hodgkin Lymphomas
Authors: Nikhil P. Mankuzhy, Brandon S. Imber, Paige Pammer, Beatrice Fregonese, Adriana Cajo, Gustav Cederquist, Alexandra Dreyfuss, Kaitlyn Lapen, Roshal R. Patel, Zachary R. Moore, Carla Hajj, Gilles Salles, Joachim Yahalom
Journal: Blood (2024)
Impact of Ptcy on Early Cardiac Toxicity after HLA-Matched Allo-HCT in Patients with Acute Myeloid Leukemia. Study on Behalf of the Grupo Español De Trasplante Hematopoyético y Terapia Celular (GETH-TC)
Authors: Maria Queralt Salas, Enric Cascos, Estefanía Pérez López, Mónica Baile González, Carlos Martín-Rodriguez, Maria Jesús Pascual, Marta Luque, Albert Esquirol, Carmen Martin Calvo, Felipe Peña, Inmaculada Heras, Adolfo Jesús Sáez Marín, Itziar Oiartzabal Ormategui, Sara Fernandez-Luis, Juan Dominguez Garcia, Sara Villar, Miguel Fernandez de Sanmamed Girón, Leslie González, José Luis López Lorenzo, Lucia García Mañó, Ana Pilar Gonzalez, Tamara Torrado, Silvia Filafferro, Pascual Balsalobre, Alberto López, Guillermo Orti, Manuel Jurado Chacón
Journal: Blood (2024)
Clinical Characteristics of Myeloproliferative Neoplasms in Patients with <i>DDX41</i>MT Germline Predisposition Syndrome
Authors: Yael Kusne, Talha Badar, Terra L. Lasho, Ludovica Marando, Abhishek A. Mangaonkar, Christy Finke, James M. Foran, Aref Al-Kali, Hassan B Alkhateeb, Naseema Gangat, Jeanne Palmer, David Viswanatha, Mark R. Litzow, Animesh D. Pardanani, Ayalew Tefferi, Timothy Chlon, Alejandro Ferrer, Mrinal M. Patnaik
Journal: Blood (2024)
Similarities and Differences of <i>DNMT3A</i>, <i>TET2</i> and <i>ASXL1</i> Mutations across Ccus, MDS and AML
Authors: Sandra Huber, Stephan Hutter, Constance Regina Baer, Manja Meggendorfer, Gregor Hoermann, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood (2024)
Comparison of Tacrolimus/Methotrexate and Post-Transplant Cyclophosphamide Graft-Versus Host Disease Prophylaxis for Haploidentical and Matched Allogeneic Stem Cell Transplantation Demonstrates Improved Overall Survival and Reduced Mortality, Shorter Length of Stay, Less Peritransplant Toxicity with Post-Transplant Cyclophosphamide
Authors: Noah Merin, Haein Kim, Yuliya Linhares, Akil Merchant, Justin M. Darrah, Joshua Sasine, Hannah Lee, Robert Allen Vescio, David Oveisi, Brittany McGalliard, Ali Rejali, Patricia VanStrien, Ellen B. Klapper, Behrooz Hakimian, John Chute, Ronald Paquette
Journal: Blood (2024)
Clinical Benefits of Achieving Hemoglobin (Hb) Levels ≥ 10 g/dL in Transfusion-Dependent (TD) Erythropoiesis-Stimulating Agent (ESA)-Naive Patients (Pts) with Lower-Risk (LR) Myelodysplastic Syndromes (MDS) Treated with Luspatercept in the COMMANDS Trial
Authors: Valeria Santini, Amer M. Zeidan, Uwe Platzbecker, Rami S. Komrokji, Guillermo Garcia-Manero, Dimana Miteva, Aylin Yucel, Veronika Pozharskaya, Shelonitda Rose, Yinzhi Lai, Ana Carolina Giuseppi, David Valcárcel Ferreiras, Pierre Fenaux, Jake Shortt, Matteo Giovanni Della Porta
Journal: Blood (2024)
Early Mixed Lymphoid Chimerism in Acute Myeloid Leukemia Patients Undergoing Allogeneic Transplantation after a Myeloablative Busulfan-Based Conditioning Regimen
Authors: Gianluca Cavallaro, Chiara Pavoni, Alessandra Algarotti, Maria Caterina Micò, Anna Grassi, Federico Lussana, Maria Chiara Finazzi, Giuliana Rizzuto, Benedetta Rambaldi, Anna Salvi, Orietta Spinelli, Alessandro Rambaldi
Journal: Blood (2024)
Treatment with Venetoclax Positively Modulates Immunological Parameters and T-Cell Features in Patients with Chronic Lymphocytic Leukemia
Authors: Valentina Griggio, Candida Vitale, Rebecca Jones, Giorgia Mancin, Giulia Bondielli, Andrea Visentin, Riccardo Moia, Anna Maria Frustaci, Veronica Mattiello, Marzia Varettoni, Francesca Perutelli, Maria Chiara Montalbano, Giacomo Ortone, Gioacchino Catania, Paolo Sportoletti, Luca Laurenti, Francesca Romana Mauro, Lorella Orsucci, Luca Arcaini, Francesco Passamonti, Marina Deodato, Gianluca Gaidano, Livio Trentin, Benedetto Bruno, Marta Coscia
Journal: Blood (2024)
Patient and Caregiver Preferences for Hemophilia Prophylactic Treatments: A Discrete Choice Experiment
Authors: Hui Lu, Jenny Whitty, Travis Gould, Carmine Colavecchia, Josh Coulter, Nicola Dunn, Pratima Chowdary, Lisa J Wilcox, Joseph C. Cappelleri, Stephanie A Christopher, Alexis Sohn, Brett Hauber
Journal: Blood (2024)
ASXL1 Mutations at Diagnosis Did Not Impact on the Depth of Molecular Response (MR) and on Treatment-Free Remission (TFR) Eligibility in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (pts) Receiving either Nilotinib (NIL) First-Line or Imatinib (IM) with Early Switch to NIL in Case of No Optimal Response in the SUSTRENIM Clinical Trial
Authors: Simona Soverini, Sara De Santis, Cecilia Monaldi, Manuela Mancini, Valentina Giai, Marco Cerrano, Isabella Capodanno, Massimiliano Bonifacio, Elisabetta Abruzzese, Alessandra Iurlo, Fausto Castagnetti, Rosaria Sancetta, Luciano Levato, Carmen Fava, Mario Tiribelli, Francesco Cavazzini, Maria Cristina Miggiano, Niccolò Bolli, Agostino Tafuri, Alessandro Lucchesi, Daniele Vallisa, Monia Lunghi, Caterina Musolino, Samantha Bruno, Cristina Mosca, Mauro Ciriello, Giovanni Marsili, Alfonso Piciocchi, Paola Fazi, Michele Cavo, Jeroen J.W.M. Janssen, Peter E. Westerweel, Fabrizio Pane
Journal: Blood (2024)
Distinct Impact of Platinum Chemotherapies on the Fitness and Genome of Hematopoietic Stem Cells and the Risk of Therapy-Related Myeloid Neoplasms
Authors: Jeremy Connors, Linda Zhang, Hidetaka Uryu, Koji Sasaki, Jennifer Padilla, Zongrui Li, Ken Furudate, Tomoyuki Tanaka, Courtney D. DiNardo, Nicholas J. Short, Naval Daver, Gautham Borthakur, Farhad Ravandi, Tapan M. Kadia, Hagop M. Kantarjian, Elias Jabbour, Simona Colla, Branko Cuglievan, Andrew Futreal, Adam S. Sperling, Guillermo Garcia-Manero, Margaret Goodell, Koichi Takahashi
Journal: Blood (2024)
Impact of Donor Type on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis
Authors: Juan Carlos Hernandez Boluda, Vipul Sharad Sheth, Simona Iacobelli, Linda Koster, Nicolaus Kröger, Simona Sica, Thomas Schroeder, Regis Peffault De Latour, Emanuele Angelucci, Didier Blaise, Henrik Sengeloev, Jakob Passweg, Matthias Stelljes, Robert Zeiser, Ibrahim Yakoub-Agha, Andrew Clark, Urpu Salmenniemi, Piero Galieni, Werner Rabitsch, Kavita K Raj, Joanna Drozd-Sokolowska, Marie Robin, Giorgia Battipaglia, Nicola Polverelli, Tomasz Czerw, Donal P McLornan
Journal: Blood (2024)
A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) with ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD) in Matched Donor Hematopoietic Cell Transplants (HCT)
Authors: Irwin Walker, Uday Deotare, Mohamed Elemary, Mahmoud Elsawy, Genevieve Gallagher, David Kliman, Tony Panzarella, Nada Hamad, Kirk R. Schultz, Jan Storek, Kristjan Paulson
Journal: Blood (2024)
Prediction of Poor Survival after Hematopoietic Cell Transplantation in Myelofibrosis Using Machine Learning Techniques
Authors: Juan Carlos Hernandez Boluda, Adrian Mosquera Orgueira, Luuk Gras, Linda Koster, Joe Tuffnell, Nicolaus Kröger, Emanuele Angelucci, Thomas Schroeder, Marie Robin, Martin Bornhäuser, Jakob Passweg, Igor Wolfgang Blau, Ibrahim Yakoub-Agha, Annoek E. C. Broers, Matthias Stelljes, Henrik Sengeloev, Jan Vydra, Uwe Platzbecker, Jurgen Kuball, Frederic Baron, Kristina Carlson, Javier Rojas, Carlos Pérez Míguez, Davide Crucitti, Kavita K Raj, Joanna Drozd-Sokolowska, Giorgia Battipaglia, Nicola Polverelli, Tomasz Czerw, Donal P McLornan
Journal: Blood (2024)
ROR1-Signaling Increases Levels of Mutant TP53 Protein and Cyclin A1 Via Activation of NRF2, Potentially Potentiating Genomic Instability in Chronic Lymphocytic Leukemia Cells with Del(17p)
Authors: Emanuela M. Ghia, Michael Y. Choi, George F. Widhopf II, Thomas J. Kipps
Journal: Blood (2024)
Abatacept Abrogates the Risk of Acute GvHD in Both Matched and Mismatched Transplantation for Haemoglobinopathies and Bone Marrow Failure
Authors: Daniel Dexter, Farah O'Boyle, Kirstin Lund, Toni Petterson, Adam Gassas, Leena Karnik, Josu de la Fuente, Sandrine Bremathas, Kelly Hennessy
Journal: Blood (2024)
What Is the Optimal Dose of MMF in Single Cord Blood Transplantation?: A Single-Center Analysis of MMF Dosage for GVHD Prophylaxis and Its Impact on Outcomes
Authors: Jotaro Yamamoto, Hisashi Yamamoto, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Aya Nishida, Shinsuke Takagi, Kazuya Ishiwata, Go Yamamoto, Yuki Asano-Mori, Atsushi Wake, Naoyuki Uchida
Journal: Blood (2024)
Sequential Intensified Conditioning Regimen Allogeneic Transplantation in Younger Adult Patients with Adverse-Risk Acute Myeloid Leukemia: A Multi-Center Prospective Study from the Acute Leukemia French Intergroup on Behalf of the Filo, ALFA, and SFGM-TC Study Groups
Authors: Regis Peffault de Latour, Edouard Forcade, Anne Huynh, Mathieu Leclerc, Stéphanie Nguyen Quoc, Patrice Ceballos, Jean-Baptiste Méar, Michael Loschi, Helene Labussiere-vallet, Jean-Henri Bourhis, Bruno Lioure, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sylvie François, Claude-Éric Bulabois, Sylvain Chantepie, Marie-Thérèse Rubio, Patrice Chevallier, Anne Lise Mesnard, Delphine Lebon, Jean Valere Malfuson, Jérôme Cornillon, Etienne Daguindau, Pascal Turlure, Natacha Maillard, Alban Villate, Marie Robin, Nicole Raus, Jean-Yves Cahn, Arnaud Pigneux, Mathilde Hunault, Christian Recher, Hervé Dombret, Gerard Socie, Jean François Hamel, Raynier Devillier
Journal: Blood (2024)
Influence of Myeloma Cell Expressed CD28 and CD86 on BCMA CAR T Cell Efficacy and Immune Effector Cell Associated Neurotoxicity Syndrome (ICANS)
Authors: Ehsan Malek, Kimberly Crasti, Grant Schofield, Shernan G. Holtan, Megan M Herr, Marco Davila, You-Wen Qian, Brian Betts, Mackenzie Lieberman, Jason Tong, Colin Chavel, Kelvin P. Lee, Scott Olejniczak
Journal: Blood (2024)
Characteristics of Pediatric and Adolescents and Young Adults (AYA) with Chronic Myeloid Leukemia: Data from the Canarian Registry of CML
Authors: Leticia Morales Espino, Ruth Stuckey, Antonio Molinés Honrubia, Adrián Segura-Díaz, Santiago Sánchez-Sosa, Sunil Lakhwani, José David González San Miguel, Nuria Hernanz Soler, Marina Gordillo, Gloria González Brito, Maria Tapia Torres, Yanira Florido, Cristina Bilbao-Sieyro, María Teresa Gómez Casares
Journal: Blood (2024)
Emicizumab and Immune Tolerance Induction in People with Hemophilia A and Factor VIII Inhibitors: 96-Week Interim Analysis of the AKATSUKI Study
Authors: Azusa Nagao, Keiji Nogami, Nobuaki Suzuki, Chiai Nagae, Masahiko Ando, Yachiyo Kuwatsuka, Daisuke Nosaka, Yui Kyogoku, Tomomi Shimura, Tadashi Matsushita
Journal: Blood (2024)
Intermediate Dose Post-Transplant Cyclophosphamide Is Associated with Faster Engraftment and Similar Other Outcomes When Compared with Full Dose Post-Transplant Cyclophosphamide Among Patients Undergoing Allogeneic Transplantation: A Single Center Retrospective Analysis
Authors: Joseph Rimando, Michel Conn, William Blum, Jason T Romancik, Colin Vale, Amelia Langston, Edmund K. Waller, Kevin Hall
Journal: Blood (2024)
Long-Term Safety and Efficacy of Treosulfan-Based Conditioning Regimens of Allogeneic Hematopoietic Cell Transplantation
Authors: Eleni Gavriilaki, Despina Mallouri, Grigorios Salvaras, Panagiotis Dolgyras, Christos Demosthenous, Ioannis Batsis, Anna Vardi, Ioannis Papadopoulos, Zoi Bousiou, Georgios Karavalakis, Christos Varelas, Alkistis Kyra Panteliadou, Nikolaos Spyridis, Antonia Syrigou, Anastasia Marvaki, Maria Papathanasiou, Apostolia Papalexandri, Chrysavgi Lalayanni, Chrysanthi Vadikoliou, Anastasia Athanasiadou, Evangelia Yannaki, Ioanna Sakellari
Journal: Blood (2024)
Treatment-Free Remission in CML Patients Discontinuing Post-First Line Therapy
Authors: Selene Grano, Valentina Bonuomo, Emanuele Koumantakis, Paola Berchialla, Fausto Castagnetti, Massimo Martino, Chiara Elena, Monica Bocchia, Isabella Capodanno, Tamara Intermesoli, Maria Cristina Miggiano, Carlo Gambacorti-Passerini, Alessandra Iurlo, Francesca Lunghi, Luigiana Luciano, Elisabetta Abruzzese, Angelo Michele Carella, Massimo Breccia, Felicetto Ferrara, Sabrina Leonetti Crescenzi, Barbara Scappini, Marco De Gobbi, Federica Sorà, Davide Rapezzi, Debora Luzi, Sara Galimberti, Monica Crugnola, Anna Rita Scortechini, Alessandro Maggi, Massimiliano Bonifacio, Mario Annunziata, Giovanni Caocci, Germana Beltrami, Francesco Cavazzini, Giuseppe Pietrantuono, Leonardo Campiotti, Fabio Stagno, Caterina Musolino, Carmen Fava
Journal: Blood (2024)
Early Obinutuzumab Significantly Increases Bone Marrow Undetectable MRD (10-4 sensitivity) (uMRD4) Rate When Combined with Acalabrutinib and Venetoclax in a Randomized Phase II Trial for Treatment Naïve CLL
Authors: Mahesh Swaminathan, Philip A. Thompson, Jan A. Burger, Musa Yilmaz, Nitin Jain, Tapan M. Kadia, Lucia Masarova, Yesid Alvarado Valero, Prithviraj Bose, Alessandra Ferrajoli, Ghayas C. Issa, Steven M. Kornblau, Farhad Ravandi, Koji Sasaki, Gautam Borthakur, Kelly S. Chien, Courtney D. DiNardo, Danielle Hammond, Elias Jabbour, Guillermo Montalban-Bravo, Naveen Pemmaraju, Nicholas J. Short, Koichi Takahashi, Francesco Paolo Tambaro, Wei Qiao, Naveen Garg, Michael J. Keating, William G. Wierda
Journal: Blood (2024)
Treosulfan/Fludarabine Versus Thiotepa/Busulfan/Fludarabine for Allogeneic Hematopoietic Cell Transplantation in Patients with Lymphomas in the Ptcy Era: A Study on Behalf of the Grupo Español De Trasplante y Terapia Celular (GETH-TC)
Authors: Marta Peña, Lorenzo Lazzari, Diego Fernando Martinez Moreno, Fabio Ciceri, Aitana Balaguer Rosello, Jaime Sanz, Maria Jesus Pascual, Ana Benzaquen, Jose Luis Piñana, Felipe Peña, Maria Queralt Salas, Agustin Nieto, Ignacio Español, Maria huguet Mas, Leyre Bento De Miguel, Adolfo Jesús Sáez Marín, Pere Barba, Silvia Filaferro, Alberto Mussetti, Raffaella Greco
Journal: Blood (2024)
Circulating and Synovial Fluid Levels of YKL-40 Protein in Patients with Hemophilia and Arthropathy: Preliminary Observations
Authors: Aikaterini Michalopoulou, Anna Kouramba, Aimilia Mantzou, Styliani-Despoina Christidi, Athina Dettoraki, George Thivaios, Zoey Kapsimali, Olga Katsarou Fasouli, Ioannis Papassotiriou, Helen Pergantou
Journal: Blood (2024)
Endothelial Dysfunction and Risk of Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation: END-GAME Prospective Study Final Results
Authors: Antonio Bianchessi, Irene Defrancesco, Virginia Valeria Ferretti, Cristina Picone, Beatrice Ferrari, Caterina Zerbi, Francesco Romano, Giulia Losi, Erica Consensi, Mara De Amici, Giorgia Testa, Valentina Zoboli, Alessia Taurino, Anna Amelia Colombo, Luca Arcaini, Nicola Polverelli
Journal: Blood (2024)
A Therapeutic siRNA Targeting Plasminogen Acts As a Long-Lasting Antifibrinolytic in Nonhuman Primates
Authors: Amy W Strilchuk, Lih Jiin Juang, Andrew Winterborn, Lori Harpell, Abbey Pender, Aomei Mo, Fateme Babaha, Christian J. Kastrup, David Lillicrap
Journal: Blood (2024)
Abscopal Effect of Radiotherapy and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: Results of the International GHSG Phase II Aern Trial
Authors: Paul J. Bröckelmann, Ina Bühnen, Josée M Zijlstra, Stephan Mathas, Katrin S Roth, Maria Garcia-Marquez, Christian Sillaber, Julia Meissner, Alexander Fossa, Richard Greil, Karolin Trautmann-Grill, Johannes Rosenbrock, Wouter Plattel, Hans A Schlösser, Carsten Kobe, Michael Fuchs, Peter Borchmann, Christian Baues
Journal: Blood (2024)
Trial in Progress: A Multicenter, Open Label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients Who Are Not Candidates for Intensive Therapy
Authors: Gail J. Roboz, Ahmed Aribi, Adrian Ochsenbein, Carsten Riether, Monic J. Stuart, Emily Mitchell, Komal Changela, Adam George, Michael Boyiadzis, Clayton Smith, Thomas Pabst
Journal: Blood (2024)
Phase 1/2, Open-Label, Multi-Center Study Assessing the Safety, Tolerability and Preliminary Efficacy of CD123 Natural Killer Cell Engager (NKCE), SAR443579, in Combination with Venetoclax and Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy
Authors: Anthony S. Stein, Emma Searle, Sylvain Garciaz, Uma Borate, Kyle Jensen, Asma Kefsi, Marie Bernardo, Yue Yang, Sarah Cooley, Ashish Bajel
Journal: Blood (2024)
Tyrosine Kinase Inhibitors Short Exposure in Pregnant Female Patients with Chronic Myeloid Leukemia
Authors: Yingling Zu, Huifang Zhao, Jianling Chen, Huibing Dang, Yanrong Shi, Lixin Liang, Shuhao Mei, Wenyi Lu, Jian Zhou, Yongping Song, Yanli Zhang
Journal: Blood (2024)
Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin (P-GVD) for Classical Hodgkin Lymphoma (CHL) in the Real-World Setting
Authors: Grace T. Baek, Gaurav Varma, Samuel Yamshon, Herman van Besien, Nancy L. Bartlett, Marcus P. Watkins, Harsh R. Shah, Kelsey Baron, Reid W. Merryman, Ayo S Falade, Jakub Svoboda, Sara Prischak, Christopher R D'Angelo, Joe D. Lukowski, Ranjana H. Advani, Austin H. Yeung, Maya C. Rosenberg, Jenna M. Voutsinas, Mengyang Di, Ryan C Lynch, Christina Poh, Vikram Raghunathan, Mazyar Shadman, Stephen D. Smith, Brian G. Till, Chaitra S. Ujjani, Catherine S. Diefenbach, Ajay K. Gopal
Journal: Blood (2024)
Clinically Driven Algorithms Identify Patients with Large Granular Lymphocytic Leukemia at Risk of Significant Cytopenia Requiring Treatment
Authors: Ahmad Kiwan, Tariq Kewan, Carlos Bravo-Perez, Valeria Visconte, Carmelo Gurnari, Arda Durmaz, Alexa Siddon, Stephanie Halene, Tarsheen Sethi, Jaroslaw Maciejewski, Francine M. Foss
Journal: Blood (2024)
Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study
Authors: Alexandra Dreyfuss, Nivetha Ganesan, Alvaro J Alencar, Alexander P. Boardman, Philip Caron, Tiffany Chang, Theresa Davey, Kevin A. David, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Beatrice Fregonese, Paola Ghione, Paul A. Hamlin, Steven Horwitz, Brandon S. Imber, Andrew M. Intlekofer, Derek Isrow, Erel Joffe, William T. Johnson, Anita Kumar, Michael Lariviere, Jennifer Kimberly Lue, Efrat Luttwak, Michael McNicholas, Zachary Moore, Brittney Munayirji, Ariela Noy, Colette Owens, Maria Lia Palomba, Jaldhi Patel, John P Plastaras, Alayna M. Santarosa, Heiko Schoder, Gunjan L. Shah, Raphael E. Steiner, Robert Stuver, Jakub Svoboda, Pallawi Torka, Santosha A. Vardhana, Andrew D. Zelenetz, Gilles Salles, Joachim Yahalom, Craig H. Moskowitz, Alison Moskowitz
Journal: Blood (2024)
Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications
Authors: Yi Zhang, Hu Zhou, Shanshan Suo, Junling Zhuang, Linhua Yang, Aili He, Qingchi Liu, Xin Du, Sujun Gao, Yarong Li, Yan Li, Yuqing Chen, Wen Wu, Huanling Zhu, Guangsheng He, Mei Hong, Qian Jiang, Zhongxing Jiang, Hongmei Jing, Jishi Wang, Na Xu, Lingling Yue, Cuiping Zheng, ZePing Zhou, Chenghao Jin, Xin Li, Lin Liu, Yajing Xu, Dengshu Wu, Feng Zhang, Jin Zhang, Zhijian Xiao, Jie Jin
Journal: Blood (2024)
Phase 2 Multicenter Trial of Tagraxofusp in Combination with Venetoclax and Azacitidine in Adults with Previously Untreated CD123+ Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
Authors: Naval Daver, Naveen Pemmaraju, Mikkael A. Sekeres, Amir T. Fathi, Andrew A. Lane, Anna Compagnoni, Ira Gupta, Alessandra Tosolini, Jessica Garzon, Hagop M. Kantarjian
Journal: Blood (2024)
Single-Cell Multi-Omics Reveals Anticipated Erythroid Differentiation and Transcriptional Regulation in Differentiation Trajectories of SF3B1 - JAK2/MPL Mutated Cells in MDS/MPN-RS-T
Authors: Matteo Zampini, Gabriele Todisco, Alice Chiodi, Chiara Chiereghin, Elena Saba, Francesco Gandolfi, Denise Ventura, Nicole Pinocchio, Laura Crisafulli, Matteo Brindisi, Alessia Campagna, Alberto Termanini, Luca Lanino, Marta Ubezio, Giulia Maggioni, Antonio Russo, Alessandro Buizza, Elisabetta Sauta, Gianluca Asti, Saverio D'Amico, Veronica Vallelonga, Serena ML Ghisletti, Ettore Mosca, Francesca Ficara, Matteo Giovanni Della Porta
Journal: Blood (2024)
Trends in Outcomes and Hospitalization of Gastrointestinal Bleeding in Patients with Myeloproliferative Neoplasms- an Analysis of the National Inpatient Sample (NIS) (2016-2020)
Authors: Sangam Sangam, Tripti Jain, Marco Bermudez, Yemesrach Mekonen, Francisco Gallegos Koyner, Shorabh Sharma
Journal: Blood (2024)
Gut Microbiota Promote Chronic Inflammation in <i>Jak2</i>V617F Mice
Authors: Hui Hui Li, Althea Agdamag, Zixing Huang, Anisa A. Gumerova, Georgii Pevnev, Paul S. Frenette, Mone Zaidi, Jeffrey A. Glassberg, Yelena Ginzburg, Ronald Hoffman
Journal: Blood (2024)
Global Manufacturing Experience with Idecabtagene Vicleucel in Patients with Relapsed and Refractory Multiple Myeloma
Authors: Surbhi Sidana, Christof Scheid, Peter J. Mueller, Petra Schuberth, Hardik Modi, Peter Krengel, Romain Piault, Xiaobo Zhong, Paula Rodríguez-Otero
Journal: Blood (2024)
Cytogenetic Abnormalities in Polycythemia Vera: Phenotypic Correlates and Prognostic Relevance in 669 Informative Cases
Authors: Moazah Iftikhar, Masooma S Rana, Yamna Jadoon, Maymona Abdelmagid, Kaaren K. Reichard, Cinthya Zepeda Mendoza, Animesh D. Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood (2024)
Single Cell Multiomic Analysis of Bone Marrow Hematopoietic Stem/Progenitor Cells from Individuals with Clonal Hematopoiesis Reveals Potential Mechanisms of Anemia Development
Authors: Michele C Buck, Jennifer Rivière, Anna Navarro Figueredo, Daniele Scarcella, Maximilian Buser, Judith S. Hecker, Mark van der Garde, Carsten Marr, Katharina S. Götze
Journal: Blood (2024)
A Phase 1 Study Investigating the Safety and Efficacy of Danvatirsen As Monotherapy Followed By Combination with Venetoclax in Patients with Relapsed/Refractory MDS and AML
Authors: Aditi Shastri, Mendel Goldfinger, Ioannis Mantzaris, Guillermo Garcia-Manero, Tapan M. Kadia, Jing Ning, Balda Tirone, Rikin Gandhi, Farhad Ravandi, Naveen Pemmaraju, Guillermo Montalban-Bravo, Annemarie Munoz, Michelle Golez, Lianchun Xiao, Kith Pradhan, Karen Fehn, Lamisha Shah, Hui Zhang, Samarpana Chakraborty, Eric J. Feldman, Nicholas J. Short, Jayastu Senapati, Dennis L Cooper, Alejandro Sica, Noah Kornblum, Lauren Shapiro, Nishi Shah, Susan MacIntyre, Ulrich Steidl, Amit Verma, Kira Gritsman, Andrew Denker, Marina Konopleva, Naval Daver
Journal: Blood (2024)